<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <title>Planetaki Planet health</title>
  <link href="http://www.planetaki.com/health" rel="alternate"/>
  <updated>2008-05-20T12:01:58+00:00</updated>
  <id>planetaki.com:1336</id>
  <author>
    <name>Planetaki - Planet health</name>
    <email>hello@planetaki.com</email>
  </author>
  <entry>
    <title>The Air Diet: Why Eat When You Can Pretend!</title>
    <updated>2010-03-10T10:55:11+00:00</updated>
    <published>2010-03-10T10:00:22+00:00</published>
    <id>planetaki.com:1336:post:67171144</id>
    <link href="http://feedproxy.google.com/~r/diet-blog/~3/g3ZdmooNtD8/the_air_diet_why_eat_when_you_can_pretend.php" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67171144" rel="full"/>
    <summary type="html">&lt;p&gt;&lt;img src="http://www.diet-blog.com/archives/madonna.jpg" onload="resizeImage( this )"/&gt;&lt;/p&gt;&lt;p&gt;Brace yourself for the silliest fad diet yet -- it's called the &lt;em&gt;Air Diet!&lt;/em&gt;&lt;/p&gt;</summary>
    <content type="html">&lt;img src="http://www.diet-blog.com/archives/madonna.jpg" onload="resizeImage( this )" /&gt;

&lt;p&gt;Brace yourself for the silliest fad diet yet -- it's called the &lt;em&gt;Air Diet!&lt;/em&gt; &lt;/p&gt;

&lt;p&gt;A French-created weight loss plan where you consume, well you've probably guessed it, nothing at all!&lt;/p&gt;

&lt;p&gt;The diet was apparently made popular by a Dolce &amp; Gabbana campaign, which featured Madonna and other celebrities holding food up to their mouths, but not eating it.&lt;/p&gt;&lt;p&gt;&lt;a href="http://www.diet-blog.com/archives/2010/03/10/the_air_diet_why_eat_when_you_can_pretend.php" title="Continue Reading: The Air Diet: Why Eat When You Can Pretend!" target="_blank"&gt;&lt;b&gt;Continue reading...&lt;/b&gt;&lt;/a&gt;&lt;p&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/diet-blog/~4/g3ZdmooNtD8" height="1" onload="resizeImage( this )" width="1" /&gt;&lt;/p&gt;</content>
    <source>
      <id>http://www.diet-blog.com/archives/2010/03/10/the_air_diet_why_eat_when_you_can_pretend.php</id>
      <link href="http://feedproxy.google.com/~r/diet-blog/~3/g3ZdmooNtD8/the_air_diet_why_eat_when_you_can_pretend.php" rel="alternate"/>
      <title>The Air Diet: Why Eat When You Can Pretend!</title>
      <updated>2010-03-10T10:55:11+00:00</updated>
      <rights>Copyright 2010</rights>
    </source>
  </entry>
  <entry>
    <title>How Do I Work Out My Calorie Requirements? [Forum]</title>
    <updated>2010-03-10T10:55:11+00:00</updated>
    <published>2010-03-10T09:40:00+00:00</published>
    <id>planetaki.com:1336:post:67171145</id>
    <link href="http://feedproxy.google.com/~r/diet-blog/~3/LrZwi9kbxGI/want-to-get-in-shape.php" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67171145" rel="full"/>
    <summary type="html">&lt;p&gt;I'm 19 and 7'5. I weigh 156. I don't really look overweight but i am absolutely in no way in shape. I would like to weigh a little less as well. &lt;/p&gt;&lt;p&gt;I bought some exercise videos to do daily and trying to figure out how I can balance out what I eat. I have a very odd schedule right now, so I don't eat too often. I'm a night nanny, so I am awake all night. I get to sleep at 7am to 3pm, then work out and eat a light meal. Then I'll eat dinner around 8pm before I have to get ready to go to work again. I haven't been feeling too well lately and don't know why that is. &lt;/p&gt;&lt;p&gt;How do I know how many calories I need daily?&lt;/p&gt;</summary>
    <content type="html">&lt;p&gt;I'm 19 and 7'5. I weigh 156. I don't really look overweight but i am absolutely in no way in shape. I would like to weigh a little less as well. &lt;/p&gt;

&lt;p&gt;I bought some exercise videos to do daily and trying to figure out how I can balance out what I eat. I have a very odd schedule right now, so I don't eat too often. I'm a night nanny, so I am awake all night. I get to sleep at 7am to 3pm, then work out and eat a light meal. Then I'll eat dinner around 8pm before I have to get ready to go to work again. I haven't been feeling too well lately and don't know why that is. &lt;/p&gt;

&lt;p&gt;How do I know how many calories I need daily?&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/diet-blog/~4/LrZwi9kbxGI" height="1" onload="resizeImage( this )" width="1" /&gt;</content>
    <source>
      <id>http://www.diet-blog.com/share/2010/03/want-to-get-in-shape.php</id>
      <link href="http://feedproxy.google.com/~r/diet-blog/~3/LrZwi9kbxGI/want-to-get-in-shape.php" rel="alternate"/>
      <title>How Do I Work Out My Calorie Requirements? [Forum]</title>
      <updated>2010-03-10T10:55:11+00:00</updated>
      <rights>Copyright 2010</rights>
    </source>
  </entry>
  <entry>
    <title>Rexahn Pharmaceuticals Issued Japanese Patent For Anti-cancer Compound Archexin(R)</title>
    <updated>2010-03-10T10:55:09+00:00</updated>
    <published>2010-03-10T07:00:00+00:00</published>
    <id>planetaki.com:1336:post:67171141</id>
    <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/W0fVgy2Z974/3yHj" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67171141" rel="full"/>
    <summary type="html">&lt;p&gt;Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the Japanese Patent Office has issued a patent for its novel anti-cancer compound, Archexin&#174;.   "The Japanese patent award is another step forward in the development of one of our lead clinical drug candidates, Archexin," said Dr. Chang Ahn, Rexahn's Chairman and Chief Executive Officer...
&lt;/p&gt;&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/udg9Qfb1UKpQMsE78htkmMlyyPY/0/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/udg9Qfb1UKpQMsE78htkmMlyyPY/0/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;br/&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/udg9Qfb1UKpQMsE78htkmMlyyPY/1/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/udg9Qfb1UKpQMsE78htkmMlyyPY/1/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;/p&gt;</summary>
    <content type="html">Rexahn Pharmaceuticals, Inc. (NYSE Amex: RNN), a clinical stage pharmaceutical company commercializing potential best in class oncology and CNS therapeutics, today announced that the Japanese Patent Office has issued a patent for its novel anti-cancer compound, Archexin&#174;.   "The Japanese patent award is another step forward in the development of one of our lead clinical drug candidates, Archexin," said Dr. Chang Ahn, Rexahn's Chairman and Chief Executive Officer...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/udg9Qfb1UKpQMsE78htkmMlyyPY/0/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/udg9Qfb1UKpQMsE78htkmMlyyPY/0/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;br /&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/udg9Qfb1UKpQMsE78htkmMlyyPY/1/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/udg9Qfb1UKpQMsE78htkmMlyyPY/1/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/W0fVgy2Z974" height="1" onload="resizeImage( this )" width="1" /&gt;</content>
    <source>
      <id>http://mnt.to/f/3yHj</id>
      <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/W0fVgy2Z974/3yHj" rel="alternate"/>
      <title>Rexahn Pharmaceuticals Issued Japanese Patent For Anti-cancer Compound Archexin(R)</title>
      <updated>2010-03-10T10:55:09+00:00</updated>
      <rights>Copyright 2010 Medical News Today</rights>
    </source>
  </entry>
  <entry>
    <title>Argos Therapeutics Presents Positive Phase 2 Data Of Its Arcelis&#8482; Personalized Immunotherapy Platform In Metastatic RCC At ASCO GU Symposium</title>
    <updated>2010-03-10T10:55:08+00:00</updated>
    <published>2010-03-10T06:00:00+00:00</published>
    <id>planetaki.com:1336:post:67171142</id>
    <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/9ZKUrgo6ZT8/3yHh" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67171142" rel="full"/>
    <summary type="html">&lt;p&gt;Argos Therapeutics announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly diagnosed patients with metastatic renal cell carcinoma (mRCC). The data were discussed March 7 in a poster presentation at the ASCO Genitourinary Cancers Symposium. AGS-003 is a product of the Company's Arcelis&#8482; technology, and is a personalized, RNA-loaded, dendritic cell-based immunotherapy that is perfectly matched to each patient's unique tumor burden...
&lt;/p&gt;&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/KHZBEWuhw02xfU57fxb6WuaVKOE/0/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/KHZBEWuhw02xfU57fxb6WuaVKOE/0/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;br/&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/KHZBEWuhw02xfU57fxb6WuaVKOE/1/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/KHZBEWuhw02xfU57fxb6WuaVKOE/1/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;/p&gt;</summary>
    <content type="html">Argos Therapeutics announced the presentation of positive data from a Phase 2 trial that evaluated the safety, clinical response and immune response of AGS-003 treatment in newly diagnosed patients with metastatic renal cell carcinoma (mRCC). The data were discussed March 7 in a poster presentation at the ASCO Genitourinary Cancers Symposium. AGS-003 is a product of the Company's Arcelis&#8482; technology, and is a personalized, RNA-loaded, dendritic cell-based immunotherapy that is perfectly matched to each patient's unique tumor burden...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/KHZBEWuhw02xfU57fxb6WuaVKOE/0/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/KHZBEWuhw02xfU57fxb6WuaVKOE/0/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;br /&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/KHZBEWuhw02xfU57fxb6WuaVKOE/1/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/KHZBEWuhw02xfU57fxb6WuaVKOE/1/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/9ZKUrgo6ZT8" height="1" onload="resizeImage( this )" width="1" /&gt;</content>
    <source>
      <id>http://mnt.to/f/3yHh</id>
      <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/9ZKUrgo6ZT8/3yHh" rel="alternate"/>
      <title>Argos Therapeutics Presents Positive Phase 2 Data Of Its Arcelis&#8482; Personalized Immunotherapy Platform In Metastatic RCC At ASCO GU Symposium</title>
      <updated>2010-03-10T10:55:08+00:00</updated>
      <rights>Copyright 2010 Medical News Today</rights>
    </source>
  </entry>
  <entry>
    <title>RepRegen&#8482; Reports Potential Advance In The Repair And Regeneration Of Hard-Tissue, Such As Bone</title>
    <updated>2010-03-10T10:55:08+00:00</updated>
    <published>2010-03-10T05:00:00+00:00</published>
    <id>planetaki.com:1336:post:67171143</id>
    <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/CZqUPQKBnlk/3yHf" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67171143" rel="full"/>
    <summary type="html">&lt;p&gt;RepRegen&#8482;, the 'smart biomaterials' company previously known as BioCeramic Therapeutics, announced today that data from an in vitro study has demonstrated that its patented Strontium-based bioactive glass platform promotes osteoblast cell activity and proliferation. If in vivo studies, which are currently underway, demonstrate similar results, then RepRegen believes its platform has the potential to significantly improve the repair and regeneration of hard-tissue, such as bone...
&lt;/p&gt;&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/fEMlf8nBuiAjgRmgyBxH9GT42Iw/0/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/fEMlf8nBuiAjgRmgyBxH9GT42Iw/0/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;br/&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/fEMlf8nBuiAjgRmgyBxH9GT42Iw/1/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/fEMlf8nBuiAjgRmgyBxH9GT42Iw/1/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;/p&gt;</summary>
    <content type="html">RepRegen&#8482;, the 'smart biomaterials' company previously known as BioCeramic Therapeutics, announced today that data from an in vitro study has demonstrated that its patented Strontium-based bioactive glass platform promotes osteoblast cell activity and proliferation. If in vivo studies, which are currently underway, demonstrate similar results, then RepRegen believes its platform has the potential to significantly improve the repair and regeneration of hard-tissue, such as bone...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/fEMlf8nBuiAjgRmgyBxH9GT42Iw/0/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/fEMlf8nBuiAjgRmgyBxH9GT42Iw/0/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;br /&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/fEMlf8nBuiAjgRmgyBxH9GT42Iw/1/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/fEMlf8nBuiAjgRmgyBxH9GT42Iw/1/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/CZqUPQKBnlk" height="1" onload="resizeImage( this )" width="1" /&gt;</content>
    <source>
      <id>http://mnt.to/f/3yHf</id>
      <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/CZqUPQKBnlk/3yHf" rel="alternate"/>
      <title>RepRegen&#8482; Reports Potential Advance In The Repair And Regeneration Of Hard-Tissue, Such As Bone</title>
      <updated>2010-03-10T10:55:08+00:00</updated>
      <rights>Copyright 2010 Medical News Today</rights>
    </source>
  </entry>
  <entry>
    <title>Maker Drops Hip Device, Then Warns of Failures</title>
    <updated>2010-03-10T10:55:01+00:00</updated>
    <published>2010-03-10T04:06:48+00:00</published>
    <id>planetaki.com:1336:post:67148062</id>
    <link href="http://feeds.nytimes.com/click.phdo?i=542082bf6d29c0cb6706806f4d36fd90" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67148062" rel="full"/>
    <content type="html">A rendering of  metallic debris caused by an improperly implanted hip, as shown in instructional material about the proper positioning of a hip socket, sent from DePuy to doctors.</content>
    <source>
      <id>http://www.nytimes.com/2010/03/10/business/10device.html</id>
      <link href="http://feeds.nytimes.com/click.phdo?i=542082bf6d29c0cb6706806f4d36fd90" rel="alternate"/>
      <title>Maker Drops Hip Device, Then Warns of Failures</title>
      <updated>2010-03-10T10:55:01+00:00</updated>
      <rights>Copyright 2010
 The New York Times Company</rights>
    </source>
  </entry>
  <entry>
    <title>Economic Scene: Wishing for a Health Care Plan That Cuts Costs</title>
    <updated>2010-03-10T10:55:00+00:00</updated>
    <published>2010-03-10T04:06:43+00:00</published>
    <id>planetaki.com:1336:post:67148063</id>
    <link href="http://feeds.nytimes.com/click.phdo?i=975565fcd1e4ddd96cc66a64215aa780" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67148063" rel="full"/>
    <content type="html">President Obama held a bipartisan meeting last month to try to find agreement on health care.</content>
    <source>
      <id>http://www.nytimes.com/2010/03/10/business/economy/10leonhardt.html</id>
      <link href="http://feeds.nytimes.com/click.phdo?i=975565fcd1e4ddd96cc66a64215aa780" rel="alternate"/>
      <title>Economic Scene: Wishing for a Health Care Plan That Cuts Costs</title>
      <updated>2010-03-10T10:55:00+00:00</updated>
      <rights>Copyright 2010
 The New York Times Company</rights>
    </source>
  </entry>
  <entry>
    <title>FDA Clears biospace med's SterEOS 2D/3D Workstation For Pediatric Use In Spine</title>
    <updated>2010-03-10T07:28:15+00:00</updated>
    <published>2010-03-10T04:00:00+00:00</published>
    <id>planetaki.com:1336:post:67148069</id>
    <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/CPvF1wYzKh8/3yHd" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67148069" rel="full"/>
    <summary type="html">&lt;p&gt;biospace med announced today that it has received 510(k) clearance from the FDA (Food and Drug Administration) to market the Company's sterEOS 2D/3D workstation for pediatric use in spine applications. The Company's EOS ultra-low-dose imager previously has been FDA-cleared for use in pediatrics and adults, while sterEOS has previously been FDA-cleared for adult use in spine...
&lt;/p&gt;&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/dFiePBf59UpV8F4eQkdycuUtwtU/0/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/dFiePBf59UpV8F4eQkdycuUtwtU/0/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;br/&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/dFiePBf59UpV8F4eQkdycuUtwtU/1/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/dFiePBf59UpV8F4eQkdycuUtwtU/1/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;/p&gt;</summary>
    <content type="html">biospace med announced today that it has received 510(k) clearance from the FDA (Food and Drug Administration) to market the Company's sterEOS 2D/3D workstation for pediatric use in spine applications. The Company's EOS ultra-low-dose imager previously has been FDA-cleared for use in pediatrics and adults, while sterEOS has previously been FDA-cleared for adult use in spine...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/dFiePBf59UpV8F4eQkdycuUtwtU/0/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/dFiePBf59UpV8F4eQkdycuUtwtU/0/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;br /&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/dFiePBf59UpV8F4eQkdycuUtwtU/1/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/dFiePBf59UpV8F4eQkdycuUtwtU/1/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/CPvF1wYzKh8" height="1" onload="resizeImage( this )" width="1" /&gt;</content>
    <source>
      <id>http://mnt.to/f/3yHd</id>
      <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/CPvF1wYzKh8/3yHd" rel="alternate"/>
      <title>FDA Clears biospace med's SterEOS 2D/3D Workstation For Pediatric Use In Spine</title>
      <updated>2010-03-10T07:28:15+00:00</updated>
      <rights>Copyright 2010 Medical News Today</rights>
    </source>
  </entry>
  <entry>
    <title>New Genetic Test Helps Doctors Predict Frequency Of Genital Herpes Outbreaks</title>
    <updated>2010-03-10T07:28:14+00:00</updated>
    <published>2010-03-10T03:00:00+00:00</published>
    <id>planetaki.com:1336:post:67148070</id>
    <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/HC1QAnSQzUM/3yHc" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67148070" rel="full"/>
    <summary type="html">&lt;p&gt;Molecular dermatology research and development innovator DermaGenoma, Inc. released The HerpesDX Genetic Test for Frequent Genital Herpes. The new screening test will help doctors assess patients' risk for developing frequent Genital Herpes (HSV-2) outbreaks.   "Until now, physicians have been unable to give patients an answer to the most common question asked by recently infected Genital Herpes patients: Will I have frequent outbreaks?," says DermaGenoma CEO Andy Goren. "Using the HerpesDX genetic test, a doctor can finally assess a patient's risk for frequent outbreaks...
&lt;/p&gt;&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/4Dmy1CUdwB2e1aKEtI12jAeIL3c/0/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/4Dmy1CUdwB2e1aKEtI12jAeIL3c/0/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;br/&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/4Dmy1CUdwB2e1aKEtI12jAeIL3c/1/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/4Dmy1CUdwB2e1aKEtI12jAeIL3c/1/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;/p&gt;</summary>
    <content type="html">Molecular dermatology research and development innovator DermaGenoma, Inc. released The HerpesDX Genetic Test for Frequent Genital Herpes. The new screening test will help doctors assess patients' risk for developing frequent Genital Herpes (HSV-2) outbreaks.   "Until now, physicians have been unable to give patients an answer to the most common question asked by recently infected Genital Herpes patients: Will I have frequent outbreaks?," says DermaGenoma CEO Andy Goren. "Using the HerpesDX genetic test, a doctor can finally assess a patient's risk for frequent outbreaks...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/4Dmy1CUdwB2e1aKEtI12jAeIL3c/0/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/4Dmy1CUdwB2e1aKEtI12jAeIL3c/0/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;br /&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/4Dmy1CUdwB2e1aKEtI12jAeIL3c/1/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/4Dmy1CUdwB2e1aKEtI12jAeIL3c/1/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/HC1QAnSQzUM" height="1" onload="resizeImage( this )" width="1" /&gt;</content>
    <source>
      <id>http://mnt.to/f/3yHc</id>
      <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/HC1QAnSQzUM/3yHc" rel="alternate"/>
      <title>New Genetic Test Helps Doctors Predict Frequency Of Genital Herpes Outbreaks</title>
      <updated>2010-03-10T07:28:14+00:00</updated>
      <rights>Copyright 2010 Medical News Today</rights>
    </source>
  </entry>
  <entry>
    <title>Merck and Sanofi-Aventis Combine Animal Health Units</title>
    <updated>2010-03-10T10:55:00+00:00</updated>
    <published>2010-03-10T01:10:12+00:00</published>
    <id>planetaki.com:1336:post:67148064</id>
    <link href="http://feeds.nytimes.com/click.phdo?i=fef198702d1d69fe8453ee61590901e2" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67148064" rel="full"/>
    <content type="html">The combined business would jointly control about 29 percent of the $19 billion-a-year global market for medicines for pets and livestock.&lt;br clear="both" /&gt;
&lt;br clear="both" /&gt;
&lt;a href="http://ads.pheedo.com/click.phdo?s=fef198702d1d69fe8453ee61590901e2&amp;p=1" target="_blank"&gt;&lt;img src="http://ads.pheedo.com/img.phdo?s=fef198702d1d69fe8453ee61590901e2&amp;p=1" border="0" onload="resizeImage( this )" alt="" /&gt;&lt;/a&gt;
&lt;img src="http://a.rfihub.com/eus.gif?eui=2220" border="0" height="0" onload="resizeImage( this )" alt="" width="0" /&gt;</content>
    <source>
      <id>http://www.nytimes.com/2010/03/10/business/10drug.html</id>
      <link href="http://feeds.nytimes.com/click.phdo?i=fef198702d1d69fe8453ee61590901e2" rel="alternate"/>
      <title>Merck and Sanofi-Aventis Combine Animal Health Units</title>
      <updated>2010-03-10T10:55:00+00:00</updated>
      <rights>Copyright 2010
 The New York Times Company</rights>
    </source>
  </entry>
  <entry>
    <title>Millennium Announces First Clinical Data For TAK-700 Prostate Molecule At ASCO GU</title>
    <updated>2010-03-10T07:28:14+00:00</updated>
    <published>2010-03-10T01:00:00+00:00</published>
    <id>planetaki.com:1336:post:67148071</id>
    <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/XLyU8dOpuuY/3yH8" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67148071" rel="full"/>
    <summary type="html">&lt;p&gt;Millennium: The Takeda Oncology Company today announced the presentation of safety, pharmacokinetic and efficacy data from the Phase I portion of a Phase I/II clinical trial evaluating TAK-700 in patients with metastatic castration resistant prostate cancer (mCRPC). These data were presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), held March 5-7, 2010 in San Francisco, CA...
&lt;/p&gt;&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/dJFIU1OlXaLN7R_TmpZMu12ZUV8/0/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/dJFIU1OlXaLN7R_TmpZMu12ZUV8/0/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;br/&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/dJFIU1OlXaLN7R_TmpZMu12ZUV8/1/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/dJFIU1OlXaLN7R_TmpZMu12ZUV8/1/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;/p&gt;</summary>
    <content type="html">Millennium: The Takeda Oncology Company today announced the presentation of safety, pharmacokinetic and efficacy data from the Phase I portion of a Phase I/II clinical trial evaluating TAK-700 in patients with metastatic castration resistant prostate cancer (mCRPC). These data were presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU), held March 5-7, 2010 in San Francisco, CA...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/dJFIU1OlXaLN7R_TmpZMu12ZUV8/0/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/dJFIU1OlXaLN7R_TmpZMu12ZUV8/0/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;br /&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/dJFIU1OlXaLN7R_TmpZMu12ZUV8/1/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/dJFIU1OlXaLN7R_TmpZMu12ZUV8/1/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/XLyU8dOpuuY" height="1" onload="resizeImage( this )" width="1" /&gt;</content>
    <source>
      <id>http://mnt.to/f/3yH8</id>
      <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/XLyU8dOpuuY/3yH8" rel="alternate"/>
      <title>Millennium Announces First Clinical Data For TAK-700 Prostate Molecule At ASCO GU</title>
      <updated>2010-03-10T07:28:14+00:00</updated>
      <rights>Copyright 2010 Medical News Today</rights>
    </source>
  </entry>
  <entry>
    <title>'No proof' IVF aided by acupuncture</title>
    <updated>2010-03-10T03:18:26+00:00</updated>
    <published>2010-03-10T00:17:10+00:00</published>
    <id>planetaki.com:1336:post:67122660</id>
    <link href="http://news.bbc.co.uk/go/rss/-/2/hi/health/8558527.stm" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67122660" rel="full"/>
    <content type="html">There is no evidence acupuncture or Chinese herbal medicine boost the chance of IVF success, fertility experts warn.</content>
    <source>
      <id>http://news.bbc.co.uk/1/hi/health/8558527.stm</id>
      <link href="http://news.bbc.co.uk/go/rss/-/2/hi/health/8558527.stm" rel="alternate"/>
      <title>'No proof' IVF aided by acupuncture</title>
      <updated>2010-03-10T03:18:26+00:00</updated>
      <rights>Copyright: (C) British Broadcasting Corporation, see http://news.bbc.co.uk/2/hi/help/rss/4498287.stm for terms and conditions of reuse</rights>
    </source>
  </entry>
  <entry>
    <title>CDC: Genital Herpes Rates Still High</title>
    <updated>2010-03-10T03:18:22+00:00</updated>
    <published>2010-03-10T00:06:31+00:00</published>
    <id>planetaki.com:1336:post:67122655</id>
    <link href="http://www.webmd.com/genital-herpes/news/20100309/cdc-genital-herpes-rates-still-high?src=RSS_PUBLIC" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67122655" rel="full"/>
    <content type="html">One in six Americans between the ages of 14 and 49 have genital herpes and close to 1 in 2 black women are infected, new figures from the CDC reveal.</content>
    <source>
      <id>http://www.webmd.com/genital-herpes/news/20100309/cdc-genital-herpes-rates-still-high?src=RSS_PUBLIC</id>
      <link href="http://www.webmd.com/genital-herpes/news/20100309/cdc-genital-herpes-rates-still-high?src=RSS_PUBLIC" rel="alternate"/>
      <title>CDC: Genital Herpes Rates Still High</title>
      <updated>2010-03-10T03:18:22+00:00</updated>
      <rights>&#169;2005-2008 WebMD, LLC. All rights reserved.</rights>
    </source>
  </entry>
  <entry>
    <title>Good Health Boosts Sexual Life Expectancy</title>
    <updated>2010-03-10T03:18:22+00:00</updated>
    <published>2010-03-10T00:04:53+00:00</published>
    <id>planetaki.com:1336:post:67122656</id>
    <link href="http://www.webmd.com/sex-relationships/news/20100309/good-health-boosts-sexual-life-expectancy?src=RSS_PUBLIC" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67122656" rel="full"/>
    <content type="html">Good health may not only help you live longer, it could help you enjoy a longer, more satisfying sex life as well, a study shows.</content>
    <source>
      <id>http://www.webmd.com/sex-relationships/news/20100309/good-health-boosts-sexual-life-expectancy?src=RSS_PUBLIC</id>
      <link href="http://www.webmd.com/sex-relationships/news/20100309/good-health-boosts-sexual-life-expectancy?src=RSS_PUBLIC" rel="alternate"/>
      <title>Good Health Boosts Sexual Life Expectancy</title>
      <updated>2010-03-10T03:18:22+00:00</updated>
      <rights>&#169;2005-2008 WebMD, LLC. All rights reserved.</rights>
    </source>
  </entry>
  <entry>
    <title>'Problem kids' risk future pain</title>
    <updated>2010-03-10T03:18:26+00:00</updated>
    <published>2010-03-10T00:04:47+00:00</published>
    <id>planetaki.com:1336:post:67122661</id>
    <link href="http://news.bbc.co.uk/go/rss/-/2/hi/health/8555892.stm" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67122661" rel="full"/>
    <content type="html">Children with behavioural problems are twice as likely to suffer chronic pain as adults than others, say researchers.</content>
    <source>
      <id>http://news.bbc.co.uk/1/hi/health/8555892.stm</id>
      <link href="http://news.bbc.co.uk/go/rss/-/2/hi/health/8555892.stm" rel="alternate"/>
      <title>'Problem kids' risk future pain</title>
      <updated>2010-03-10T03:18:26+00:00</updated>
      <rights>Copyright: (C) British Broadcasting Corporation, see http://news.bbc.co.uk/2/hi/help/rss/4498287.stm for terms and conditions of reuse</rights>
    </source>
  </entry>
  <entry>
    <title>ImmunoGen, Inc. Announces Orphan Drug Designation Granted To IMGN901 For Treatment Of Merkel Cell Carcinoma By US FDA And EU COMP</title>
    <updated>2010-03-10T03:18:28+00:00</updated>
    <published>2010-03-10T00:00:00+00:00</published>
    <id>planetaki.com:1336:post:67122662</id>
    <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/ZvDyHFdCnPI/3yH7" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67122662" rel="full"/>
    <summary type="html">&lt;p&gt;ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC...
&lt;/p&gt;&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/BtmwaGJJ2zW3gRSvfppgS2uHp58/0/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/BtmwaGJJ2zW3gRSvfppgS2uHp58/0/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;br/&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/BtmwaGJJ2zW3gRSvfppgS2uHp58/1/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/BtmwaGJJ2zW3gRSvfppgS2uHp58/1/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;/p&gt;</summary>
    <content type="html">ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/BtmwaGJJ2zW3gRSvfppgS2uHp58/0/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/BtmwaGJJ2zW3gRSvfppgS2uHp58/0/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;br /&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/BtmwaGJJ2zW3gRSvfppgS2uHp58/1/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/BtmwaGJJ2zW3gRSvfppgS2uHp58/1/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/ZvDyHFdCnPI" height="1" onload="resizeImage( this )" width="1" /&gt;</content>
    <source>
      <id>http://mnt.to/f/3yH7</id>
      <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/ZvDyHFdCnPI/3yH7" rel="alternate"/>
      <title>ImmunoGen, Inc. Announces Orphan Drug Designation Granted To IMGN901 For Treatment Of Merkel Cell Carcinoma By US FDA And EU COMP</title>
      <updated>2010-03-10T03:18:28+00:00</updated>
      <rights>Copyright 2010 Medical News Today</rights>
    </source>
  </entry>
  <entry>
    <title>Vaccinating Children against Flu Helps Protect Wider Community</title>
    <updated>2010-03-10T07:28:30+00:00</updated>
    <published>2010-03-09T23:47:13+00:00</published>
    <id>planetaki.com:1336:post:67148112</id>
    <link href="http://www.nlm.nih.gov/enter/medlineplus/rss?feed=Todays%20MedlinePlus%20Health%20News&amp;url=http%3A%2F%2Fwww%2Enih%2Egov%2Fnews%2Fhealth%2Fmar2010%2Fniaid%2D09%2Ehtm" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67148112" rel="full"/>
    <content type="html">Source: National Institute of Allergy and Infectious Diseases - &lt;img class="imgdesc" title="From the National Institutes of Health" src="http://www.nlm.nih.gov/medlineplus/images/nih.gif" onload="resizeImage( this )" alt="From the National Institutes of Health" /&gt;&lt;br /&gt;
Related MedlinePlus Page: &lt;a href="http://www.nlm.nih.gov/medlineplus/flu.html" target="_blank"&gt;Flu&lt;/a&gt;</content>
    <source>
      <id>http://www.nih.gov/news/health/mar2010/niaid-09.htm</id>
      <link href="http://www.nlm.nih.gov/enter/medlineplus/rss?feed=Todays%20MedlinePlus%20Health%20News&amp;url=http%3A%2F%2Fwww%2Enih%2Egov%2Fnews%2Fhealth%2Fmar2010%2Fniaid%2D09%2Ehtm" rel="alternate"/>
      <title>Vaccinating Children against Flu Helps Protect Wider Community</title>
      <updated>2010-03-10T07:28:30+00:00</updated>
    </source>
  </entry>
  <entry>
    <title>Melanoma Cases on the Rise</title>
    <updated>2010-03-10T03:18:21+00:00</updated>
    <published>2010-03-09T23:29:47+00:00</published>
    <id>planetaki.com:1336:post:67122657</id>
    <link href="http://www.webmd.com/melanoma-skin-cancer/news/20100309/melanoma-cases-on-the-rise?src=RSS_PUBLIC" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67122657" rel="full"/>
    <content type="html">While some researchers suggest the rising rates of melanoma may simply reflect a change in how doctors diagnose melanoma and the increased availability of skin cancer screenings, a leading dermatologist says the increase is real.</content>
    <source>
      <id>http://www.webmd.com/melanoma-skin-cancer/news/20100309/melanoma-cases-on-the-rise?src=RSS_PUBLIC</id>
      <link href="http://www.webmd.com/melanoma-skin-cancer/news/20100309/melanoma-cases-on-the-rise?src=RSS_PUBLIC" rel="alternate"/>
      <title>Melanoma Cases on the Rise</title>
      <updated>2010-03-10T03:18:21+00:00</updated>
      <rights>&#169;2005-2008 WebMD, LLC. All rights reserved.</rights>
    </source>
  </entry>
  <entry>
    <title>Companies Get Poor Grades for Kids' Food Ads</title>
    <updated>2010-03-10T03:18:21+00:00</updated>
    <published>2010-03-09T23:03:14+00:00</published>
    <id>planetaki.com:1336:post:67122658</id>
    <link href="http://children.webmd.com/news/20100309/companies-get-poor-grades-for-kids-food-ads?src=RSS_PUBLIC" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67122658" rel="full"/>
    <content type="html">Most companies lack meaningful policies to curb the marketing of high-fat and high-sugar junk food to children, according to a report by a consumer watchdog group.</content>
    <source>
      <id>http://children.webmd.com/news/20100309/companies-get-poor-grades-for-kids-food-ads?src=RSS_PUBLIC</id>
      <link href="http://children.webmd.com/news/20100309/companies-get-poor-grades-for-kids-food-ads?src=RSS_PUBLIC" rel="alternate"/>
      <title>Companies Get Poor Grades for Kids' Food Ads</title>
      <updated>2010-03-10T03:18:21+00:00</updated>
      <rights>&#169;2005-2008 WebMD, LLC. All rights reserved.</rights>
    </source>
  </entry>
  <entry>
    <title>BG Medicine And Abbott To Develop Galectin-3 Test For The I-STAT(R) System</title>
    <updated>2010-03-10T03:18:28+00:00</updated>
    <published>2010-03-09T23:00:00+00:00</published>
    <id>planetaki.com:1336:post:67122663</id>
    <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/gARIAVX5nic/3yH6" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67122663" rel="full"/>
    <summary type="html">&lt;p&gt;BG Medicine, Inc. announced that it has entered into an agreement with Abbott Laboratories (NYSE: ABT) to extend its current development and commercialization collaboration to include the development of a galectin-3 test for Abbott Point of Care's i-STAT&#174; System. Galectin-3 is a novel biomarker that may play a role in detecting the development and progression of heart failure...
&lt;/p&gt;&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/kkPIEdOgNB9Y-4G9g4zdvl9rNDk/0/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/kkPIEdOgNB9Y-4G9g4zdvl9rNDk/0/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;br/&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/kkPIEdOgNB9Y-4G9g4zdvl9rNDk/1/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/kkPIEdOgNB9Y-4G9g4zdvl9rNDk/1/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;/p&gt;</summary>
    <content type="html">BG Medicine, Inc. announced that it has entered into an agreement with Abbott Laboratories (NYSE: ABT) to extend its current development and commercialization collaboration to include the development of a galectin-3 test for Abbott Point of Care's i-STAT&#174; System. Galectin-3 is a novel biomarker that may play a role in detecting the development and progression of heart failure...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/kkPIEdOgNB9Y-4G9g4zdvl9rNDk/0/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/kkPIEdOgNB9Y-4G9g4zdvl9rNDk/0/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;br /&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/kkPIEdOgNB9Y-4G9g4zdvl9rNDk/1/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/kkPIEdOgNB9Y-4G9g4zdvl9rNDk/1/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/gARIAVX5nic" height="1" onload="resizeImage( this )" width="1" /&gt;</content>
    <source>
      <id>http://mnt.to/f/3yH6</id>
      <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/gARIAVX5nic/3yH6" rel="alternate"/>
      <title>BG Medicine And Abbott To Develop Galectin-3 Test For The I-STAT(R) System</title>
      <updated>2010-03-10T03:18:28+00:00</updated>
      <rights>Copyright 2010 Medical News Today</rights>
    </source>
  </entry>
  <entry>
    <title>Vaccinate Kids to Stop Flu in Community</title>
    <updated>2010-03-09T22:55:50+00:00</updated>
    <published>2010-03-09T21:38:19+00:00</published>
    <id>planetaki.com:1336:post:67097007</id>
    <link href="http://www.webmd.com/cold-and-flu/news/20100309/vaccinate-kids-to-stop-flu-in-community?src=RSS_PUBLIC" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67097007" rel="full"/>
    <content type="html">New research confirms that giving flu shots to large numbers of school-age children can protect the community at large.</content>
    <source>
      <id>http://www.webmd.com/cold-and-flu/news/20100309/vaccinate-kids-to-stop-flu-in-community?src=RSS_PUBLIC</id>
      <link href="http://www.webmd.com/cold-and-flu/news/20100309/vaccinate-kids-to-stop-flu-in-community?src=RSS_PUBLIC" rel="alternate"/>
      <title>Vaccinate Kids to Stop Flu in Community</title>
      <updated>2010-03-09T22:55:50+00:00</updated>
      <rights>&#169;2005-2008 WebMD, LLC. All rights reserved.</rights>
    </source>
  </entry>
  <entry>
    <title>Flu Shots in Children Can Help Community</title>
    <updated>2010-03-10T10:55:01+00:00</updated>
    <published>2010-03-09T21:37:32+00:00</published>
    <id>planetaki.com:1336:post:67096997</id>
    <link href="http://feeds.nytimes.com/click.phdo?i=91ff4c39775c18429a9e9a864578181a" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67096997" rel="full"/>
    <content type="html">Nearly 50 Hutterite colonies in Canada took part in a study in which children received flu shots.</content>
    <source>
      <id>http://www.nytimes.com/2010/03/10/health/10flu.html</id>
      <link href="http://feeds.nytimes.com/click.phdo?i=91ff4c39775c18429a9e9a864578181a" rel="alternate"/>
      <title>Flu Shots in Children Can Help Community</title>
      <updated>2010-03-10T10:55:01+00:00</updated>
      <rights>Copyright 2010
 The New York Times Company</rights>
    </source>
  </entry>
  <entry>
    <title>Long-Term Health Risks Low for Kidney Donors</title>
    <updated>2010-03-09T22:55:50+00:00</updated>
    <published>2010-03-09T21:04:05+00:00</published>
    <id>planetaki.com:1336:post:67097008</id>
    <link href="http://www.webmd.com/news/20100309/low-long-term-health-risk-for-kidney-donors?src=RSS_PUBLIC" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67097008" rel="full"/>
    <content type="html">Kidney donors fare just as well as non-donors over the long term, according to a new study.</content>
    <source>
      <id>http://www.webmd.com/news/20100309/low-long-term-health-risk-for-kidney-donors?src=RSS_PUBLIC</id>
      <link href="http://www.webmd.com/news/20100309/low-long-term-health-risk-for-kidney-donors?src=RSS_PUBLIC" rel="alternate"/>
      <title>Long-Term Health Risks Low for Kidney Donors</title>
      <updated>2010-03-09T22:55:50+00:00</updated>
      <rights>&#169;2005-2008 WebMD, LLC. All rights reserved.</rights>
    </source>
  </entry>
  <entry>
    <title>Vets Welcome Extension To UK Pet Travel Protection</title>
    <updated>2010-03-10T03:18:28+00:00</updated>
    <published>2010-03-09T21:00:00+00:00</published>
    <id>planetaki.com:1336:post:67122664</id>
    <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/eVLe5GIjpR0/3yH4" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67122664" rel="full"/>
    <summary type="html">&lt;p&gt;The European Parliament has voted 618 votes to 17 for an extension to the transitional arrangements contained within the regulation on the non-commercial movement of pet animals (Reg. 998/2003) which afford the UK additional protection against rabies, ticks and tapeworms.  The British Veterinary Association (BVA) and British Small Animal Veterinary Association (BSAVA) have been lobbying MEPs to support the extension and have strongly welcomed this decision...
&lt;/p&gt;&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/tZb3n1Eae0ISsxGyHVvpM4XcvkE/0/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/tZb3n1Eae0ISsxGyHVvpM4XcvkE/0/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;br/&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/tZb3n1Eae0ISsxGyHVvpM4XcvkE/1/da" target="_blank"&gt;
      &lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/tZb3n1Eae0ISsxGyHVvpM4XcvkE/1/di" border="0" onload="resizeImage( this )"/&gt;
    &lt;/a&gt;&lt;/p&gt;</summary>
    <content type="html">The European Parliament has voted 618 votes to 17 for an extension to the transitional arrangements contained within the regulation on the non-commercial movement of pet animals (Reg. 998/2003) which afford the UK additional protection against rabies, ticks and tapeworms.  The British Veterinary Association (BVA) and British Small Animal Veterinary Association (BSAVA) have been lobbying MEPs to support the extension and have strongly welcomed this decision...
&lt;p&gt;&lt;a href="http://feedads.g.doubleclick.net/~a/tZb3n1Eae0ISsxGyHVvpM4XcvkE/0/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/tZb3n1Eae0ISsxGyHVvpM4XcvkE/0/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;br /&gt;
&lt;a href="http://feedads.g.doubleclick.net/~a/tZb3n1Eae0ISsxGyHVvpM4XcvkE/1/da" target="_blank"&gt;&lt;img ismap="true" src="http://feedads.g.doubleclick.net/~a/tZb3n1Eae0ISsxGyHVvpM4XcvkE/1/di" border="0" onload="resizeImage( this )" /&gt;&lt;/a&gt;&lt;/p&gt;&lt;img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/eVLe5GIjpR0" height="1" onload="resizeImage( this )" width="1" /&gt;</content>
    <source>
      <id>http://mnt.to/f/3yH4</id>
      <link href="http://feedproxy.google.com/~r/mnt/healthnews/~3/eVLe5GIjpR0/3yH4" rel="alternate"/>
      <title>Vets Welcome Extension To UK Pet Travel Protection</title>
      <updated>2010-03-10T03:18:28+00:00</updated>
      <rights>Copyright 2010 Medical News Today</rights>
    </source>
  </entry>
  <entry>
    <title>'Curry' Cream May Fade Wrinkles</title>
    <updated>2010-03-09T22:55:50+00:00</updated>
    <published>2010-03-09T20:39:29+00:00</published>
    <id>planetaki.com:1336:post:67097009</id>
    <link href="http://www.webmd.com/skin-beauty/news/20100309/curry-cream-may-fade-wrinkles?src=RSS_PUBLIC" rel="alternate"/>
    <link href="http://www.planetaki.com/health/posts/67097009" rel="full"/>
    <content type="html">A moisturizing cream whose active ingredient is the extract that gives Indian curry its distinctive flavor, smel,l and deep orange color may help fade fine facial lines, wrinkles, and aging spots.</content>
    <source>
      <id>http://www.webmd.com/skin-beauty/news/20100309/curry-cream-may-fade-wrinkles?src=RSS_PUBLIC</id>
      <link href="http://www.webmd.com/skin-beauty/news/20100309/curry-cream-may-fade-wrinkles?src=RSS_PUBLIC" rel="alternate"/>
      <title>'Curry' Cream May Fade Wrinkles</title>
      <updated>2010-03-09T22:55:50+00:00</updated>
      <rights>&#169;2005-2008 WebMD, LLC. All rights reserved.</rights>
    </source>
  </entry>
</feed>
